naproxen sodium and pseudoephedrine hydrochloride sinus and cold
Generic: naproxen sodium and pseudoephedrine hydrochloride
Labeler: aurohealth llcDrug Facts
Product Profile
Brand Name
naproxen sodium and pseudoephedrine hydrochloride sinus and cold
Generic Name
naproxen sodium and pseudoephedrine hydrochloride
Labeler
aurohealth llc
Dosage Form
TABLET, EXTENDED RELEASE
Routes
Active Ingredients
naproxen sodium 220 mg/1, pseudoephedrine hydrochloride 120 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
58602-816
Product ID
58602-816_554a4cb1-aaac-44f9-99c7-f342abdc3531
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA211360
Listing Expiration
2026-12-31
Marketing Start
2022-06-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
58602816
Hyphenated Format
58602-816
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
naproxen sodium and pseudoephedrine hydrochloride sinus and cold (source: ndc)
Generic Name
naproxen sodium and pseudoephedrine hydrochloride (source: ndc)
Application Number
ANDA211360 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 220 mg/1
- 120 mg/1
Packaging
- 2 BLISTER PACK in 1 CARTON (58602-816-67) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
- 3 BLISTER PACK in 1 CARTON (58602-816-72) / 8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
- 1 BLISTER PACK in 1 CARTON (58602-816-83) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Packages (3)
58602-816-67
2 BLISTER PACK in 1 CARTON (58602-816-67) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
58602-816-72
3 BLISTER PACK in 1 CARTON (58602-816-72) / 8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
58602-816-83
1 BLISTER PACK in 1 CARTON (58602-816-83) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "554a4cb1-aaac-44f9-99c7-f342abdc3531", "openfda": {"unii": ["9TN87S3A3C", "6V9V2RYJ8N"], "rxcui": ["1367426"], "spl_set_id": ["638a9664-4129-46fd-9ba1-d660a7366c9f"], "manufacturer_name": ["Aurohealth LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (58602-816-67) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "58602-816-67", "marketing_start_date": "20220601"}, {"sample": false, "description": "3 BLISTER PACK in 1 CARTON (58602-816-72) / 8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "58602-816-72", "marketing_start_date": "20250212"}, {"sample": false, "description": "1 BLISTER PACK in 1 CARTON (58602-816-83) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "58602-816-83", "marketing_start_date": "20220601"}], "brand_name": "Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Cold", "product_id": "58602-816_554a4cb1-aaac-44f9-99c7-f342abdc3531", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "58602-816", "generic_name": "Naproxen Sodium and Pseudoephedrine Hydrochloride", "labeler_name": "Aurohealth LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Cold", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA211360", "marketing_category": "ANDA", "marketing_start_date": "20220601", "listing_expiration_date": "20261231"}